CD30

A description for CD30 is coming soon.

#SimilarOrganizations #More

CD30

Industry:
Internet Software

Status:
Active


Similar Organizations

not_available_image

ADMIC Controls

A description for ADMIC Controls is coming soon.

not_available_image

Avataro

A description for Avataro is coming soon.

not_available_image

Edge Computer

A description for Edge Computer is coming soon.

not_available_image

SBMA

A description for SBMA is coming soon.

not_available_image

Wego Systems

Wego Systems description coming soon

More informations about "CD30"

Pathology Outlines - CD30

Jan 1, 2011 CD30 is a transmembrane glycoprotein, which belongs to tumor necrosis factor receptor superfamily. CD30, also known as BerH2, Ki1 or TNFRSF8, is a transmembrane glycoprotein receptor that belongs to the tumor necrosis factor receptor (TNFR) and was first โ€ฆSee details»

CD30 - Wikipedia

โ€ข Schneider C, Hübinger G (Jul 2002). "Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family". Leukemia & Lymphoma. 43 (7): 1355โ€“66. doi:10.1080/10428190290033288. PMID 12389614. S2CID 12699308. โ€ข Horie R, Higashihara M, Watanabe T (Jan 2003). "Hodgkin's lymphoma and CD30 signal transduction". International Journal of Hematology. 77 (1): 37โ€“47. doi:10.1007/BF02982601. PMID 12568298. S2CIDSee details»

Immunohistochemical Quality Control - NordiQC

Apr 22, 2015 CD30 is a member of the tumor necrosis factor receptor (TNF-R) superfamily, which comprises more than 10 different members. CD30 has an extracytoplasmic domain, โ€ฆSee details»

CD30: A DIFFERENTIATING BIOMARKER

The CD30 transmembrane receptorโ€ฆis expressed in a distinct, yet diverse set of lymphoproliferative disordersโ€ฆ.Therefore, detection of CD30 expression ... NordiQC, an โ€ฆSee details»

CD30 - MyPathologyReport.ca

CD30 is a protein made primarily by activated immune cells such as T cells and B cells.Some types of cancers that start from T cells or B cells, such as anaplastic large cell lymphoma and โ€ฆSee details»

CD30 - an overview | ScienceDirect Topics

CD30. CD30 was first described as a marker for Hodgkin lymphoma cells, but is also expressed by a subset of normal T lymphocytes. CD30 has been implicated as a costimulatory molecule โ€ฆSee details»

Targeting CD30/CD30L in Oncology and Autoimmune and

The transmembrane receptor CD30 (TNFRSF8) and its ligand CD30L (CD153, TNFSF8) are members of the tumor necrosis factor (TNF) superfamily and display restricted expression in โ€ฆSee details»

CD30 expression defines a novel subgroup of diffuse large B-cell ...

Apr 4, 2013 Introduction. Diffuse large B-cell lymphoma (DLBCL) is the most common and one of most heterogeneous types of non-Hodgkin lymphoma. It is categorized into different โ€ฆSee details»

The Polyvalent Role of CD30 for Cancer Diagnosis and Treatment

Researchers wanted to explore the effects of CD30 signaling, so they employed the C10 antibody, an agonist of human CD30, to stimulate CD30 on YT (yolk tumor) cells. Subsequent gene โ€ฆSee details»

CD30 Is a CD40-Inducible Molecule that Negatively Regulates โ€ฆ

The top graphics depict the organization of these constructs. The initiation of transcription within the wt ECS-Iฮณ3 promoter is indicated by an arrow, and numbering is such that +1 corresponds โ€ฆSee details»

Full article: CD30: receptor, marker, target - Taylor & Francis Online

CD30 is a member of the tumor necrosis factor receptor family and is expressed on activated lymphocytes and a few other normal cells. Its signaling activates NF-ฮบB transcription factor, โ€ฆSee details»

Understanding CD30 biology and therapeutic targeting: a ... - Nature

Sep 8, 2017 CD30 is a member of the tumor necrosis factor receptor superfamily. It is characteristically expressed in certain hematopoietic malignancies, including anaplastic large โ€ฆSee details»

Clinical Roundtable Monograph: CD30 in Lymphoma: Its Role in โ€ฆ

Apr 10, 2014 The extracellular portion of CD30 is subject to enzymatic cleavage by metalloproteases, resulting in the release of 85-kDa soluble CD30 in the serum and/or bodily โ€ฆSee details»

Primary Cutaneous CD30+ Lymphoproliferative Disorders: New โ€ฆ

Apr 30, 2007 The spectrum of CD30+ lymphoproliferative diseases of the skin includes CD30+ cutaneous anaplastic large cell lymphoma, lymphomatoid papulosis, as well as borderline โ€ฆSee details»

CD30 expression defines a novel subgroup of diffuse large B-cell ...

Apr 4, 2013 CD30, a member of the tumor necrosis factor receptor (TNFR) superfamily, was originally identified as a cell-surface marker of Reed-Sternberg and Hodgkin cells in classical โ€ฆSee details»

CD30 expression in nonlymphomatous malignancies.

May 20, 2012 Background: CD30 is commonly expressed in Hodgkin lymphoma (HL), anaplastic large cell lymphoma (ALCL), and testicular embryonal carcinoma. Expression of CD30 in other โ€ฆSee details»

CD30+ lymphoproliferative disorders - Haematologica

CD30 antigen, originally identified as a cell surface marker of the malignant Hodgkin and Reed-Sternberg (HRS) cells in Hodgkinโ€™s lymphoma by the use of the Ki-1 monoclonal antibody, is a โ€ฆSee details»

CD30 expression in peripheral T-cell lymphomas - PMC - PubMed โ€ฆ

CD30 antigen is a trans-membrane glycoprotein belonging to the tumor necrosis factor receptor superfamily. 1 Upon stimulation, CD30 exerts pleiotropic effects on cell growth and survival, โ€ฆSee details»

CD30-positive peripheral T-cell lymphomas share molecular and ...

In line with these observations, hierarchical clustering of the whole set of immunohistochemical scores segregated the samples into two groups according to the expression of CD30. โ€ฆSee details»

Belarus convicts well-known activist and sentences him to 6 years โ€ฆ

12 hours ago The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, โ€ฆSee details»

linkstock.net © 2022. All rights reserved